Item 2.02. Results of Operations and Financial Condition

On October 30, 2012, LeMaitre Vascular, Inc. (the "Company") issued a press release regarding its financial and operational results for the third quarter ended September 30, 2012. A copy of the press release is furnished as Exhibit 99.1 to this report.

The information in this report, including the Exhibit attached hereto, is intended to be furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 8.01. Other Events

The Company also announced that it had completed its purchase of a worldwide perpetual license and the assets to exclusively develop, manufacture and commercialize bovine and equine pericardium patches for vascular applications in humans from Neovasc Inc. and its subsidiary, Neovasc Medical Inc. for $4.6 million, of which $4.3 million is payable on the closing date and $0.3 million is payable on the one year anniversary of the closing date.

Item 9.01. Financial Statements and Exhibits

The following exhibit is furnished as part of this report, where indicated:

(d) Exhibits.

Exhibit
No. Description

99.1 Press release issued by LeMaitre Vascular, Inc. on October 30, 2012.

---